Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 05 source : Www.biospace.com save search
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
DMAC | News | $2.58 8.86% 8.14% 41K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: -2.07%
financial results results
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 0.0%
H: 1.65%
C: -0.83%
iot macular elamipretide
ADC Therapeutics’ ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
ADCT | $4.96 11.71% 1.41% 1.2M
|
Health Technology
|
| O: -0.67%
H: 2.95%
C: -1.79%
cancer t-cell
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: 0.14%
H: 2.14%
C: 2.1%
treatment fda positive therapy fda approval her2+ keytruda her2- her2
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
NVAX | $3.895 -2.38% -2.44% 3.7M
|
Health Technology
|
| O: 3.47%
H: 4.31%
C: -8.13%
covid phase 2 results vaccine phase 2b trial trial results
CENTOGENE Discovers Six New Rare Diseases by Leveraging the Strength of Its Bio/DatabankResearch leads to diagnosis and treatment options for rare disease patients
Published: 2021-05-05 (Crawled : 18:00) - biospace.com/
CNTG | $0.4801 0.14% 17K
|
Commercial Services
|
| O: 1.11%
H: 4.4%
C: -2.5%
disease treatment research rare diagnostic
United Therapeutics Corporation Reports First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 18:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.24%
H: 2.61%
C: 2.21%
UTHR | $235.44 1.58% 1.55% 370K
|
Health Technology
|
| O: 0.0%
H: 3.21%
C: 1.42%
financial results results therapeutics
Xilio Therapeutics Appoints Christina Rossi to Its Board of Directors
Published: 2021-05-05 (Crawled : 18:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.1%
H: 0.59%
C: 0.22%
therapeutics
Clinical News: MDMA and Therapy Significantly Benefits PTSD Patients and More
Published: 2021-05-05 (Crawled : 18:00) - biospace.com/
VERU | $1.165 -7.17% -7.73% 2.5M
|
Health Technology
|
| O: 20.23%
H: 6.88%
C: -15.97%
therapy
Lilly to Participate in Bank of America Securities 2021 Health Care Conference
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.24%
H: 2.61%
C: 2.21%
conference health
Longeveron Invited to Present at the Benzinga Global Small Cap Conference
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
LGVN | News P 6 d | $2.08 -41.08% -69.71% 3.3M
|
|
| O: -0.51%
H: 3.47%
C: -0.17%
conference
Scandal Watch: Elizabeth Holmes Appears in Court, Opioid Distributors on Tria...
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: -0.26%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 0.9%
H: 1.68%
C: -0.59%
opioid
Humanigen Announces Publication of Results From Phase 3 Randomized Double-Blind Placebo-Controlled Study Demonstrating the Efficacy and Safety of Lenzilumab™ in Hospitalized COVID-19 Patients
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: -1.0%
H: 12.15%
C: 6.49%
covid results lenzilumab phase 3
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
GNPX | $2.26 -1.74% -1.77% 21K
|
Health Technology
|
| O: 0.54%
H: 3.11%
C: -1.89%
lung cancer cancer trial approval
Wipro Partners with Transcell Oncologics to Transform Vaccine Safety Assessment
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
WIT | $5.25 -0.19% 0.1% 2.2M
|
Technology Services
|
| O: 2.52%
H: 0.0%
C: -0.96%
vaccine
Scandal Watch: Elizabeth Holmes Appears in Court, Opioid Distributors on Trial and More
Published: 2021-05-05 (Crawled : 17:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: -0.26%
INCY | $52.74 -0.9% -0.91% 2.5M
|
Health Technology
|
| O: 0.9%
H: 1.68%
C: -0.59%
opioid trial
MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021
Published: 2021-05-05 (Crawled : 15:00) - biospace.com/
MNKD | $4.105 1.36% 1.34% 2.3M
|
Health Technology
|
| O: 1.16%
H: 0.47%
C: -4.81%
financial results results conference
MediWound Reports First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
MDWD | $17.395 -4.84% -5.09% 160K
|
Health Technology
|
| O: 1.71%
H: 0.42%
C: -11.13%
financial results results report
Hoth Therapeutics and Virginia Commonwealth University Expand Research Agreement for COVID-19 Therapeutic
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
HOTH | $1.19 -0.83% -0.84% 24K
|
Health Technology
|
| O: 6.34%
H: 0.66%
C: 0.0%
covid research therapeutics covid-19
Carmine Therapeutics appoints Don Haut as CEO
Published: 2021-05-05 (Crawled : 14:15) - biospace.com/
MMM | $90.96 -0.1% 0.0% 3.4M
|
Producer Manufacturing
|
| O: 0.31%
H: 0.86%
C: 0.72%
ceo leo therapeutics
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.